The Anatomy of a Science-Based Business
Science Business: The Promise, the Reality, and the Future of Biotech
- チャプター
What types of firms compete in the biotechnology segment? How have these changed over time? What kind of strategies have they pursued? And what capabilities do they have? This chapter describes the emergence of biotechnology as a new segment of the pharmaceutical industry, analyzing how firm capabilities, technological strategies, and business models have evolved over time. This chapter is excerpted from "Science Business: The Promise, the Reality, and the Future of Biotech."
- 出版日
- 2006/11
- 領域
- 経営・戦略
- ボリューム
- 35ページ
- コンテンツID
- CCJB-HBS-6607BC
- オリジナルID
- 6607BC
- ケースの種類
- Press Chapter
- 言語
- 英語
- カラー
- 製本の場合、モノクロ印刷での納品となります。
関連ケース
-
The Science-Based Business: A Novel Experiment
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 1,969
¥ 1,353
-
Mapping the Scientific Landscape: Advances in the Drug Sciences
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 2,046
¥ 1,353
-
The Complex Anatomy of Drug R&D
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 1,892
¥ 1,232
-
Drug R&D and the Organizational Challenges
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 2,046
¥ 1,353
-
The Performance of the Biotech Industry: Promise Versus Reality
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 1,969
¥ 1,353
-
The Monetization of Intellectual Property: The Forces that Drive the Business of Biotechnology
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 2,123
¥ 1,463
-
Organizational Strategies and Business Models: Better Biotechnology
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 2,046
¥ 1,353
-
The Path Ahead: Toward Science-Based Enterprise
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 1,969
¥ 1,353